Production (Stage)
ABVC BioPharma, Inc.
ABVC
$1.15
-$0.06-4.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.60% | 50.38% | 4.10% | 87.97% | -23.73% |
| Total Receivables | -53.50% | -5.04% | -4.24% | 41.16% | 18.47% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.21% | 5.37% | -9.42% | -36.84% | 57.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.30% | -2.70% | 2.26% | -1.59% | -4.28% |
| Total Current Assets | -32.58% | 1.47% | -1.89% | 22.02% | 8.32% |
|
|
|||||
| Total Current Assets | -32.58% | 1.47% | -1.89% | 22.02% | 8.32% |
| Net Property, Plant & Equipment | 655.73% | -86.36% | -1.14% | -1.40% | 527.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.31% | 26.49% | 0.72% | -0.25% | -30.93% |
| Total Assets | 97.29% | -47.87% | -1.17% | 1.20% | 85.76% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -6.54% | 0.84% | -3.78% | 5.73% | 0.18% |
| Short-term Debt | -6.19% | 31.93% | 8.10% | 1.20% | 10.26% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.26% | 0.09% | 1.08% | 7.28% | -4.33% |
| Total Finance Division Other Current Liabilities | 159.99% | -26.35% | -28.02% | -33.73% | 79.60% |
| Total Other Current Liabilities | 159.99% | -26.35% | -28.02% | -33.73% | 79.60% |
| Total Current Liabilities | 2.64% | 3.83% | -3.56% | -1.28% | 8.71% |
|
|
|||||
| Total Current Liabilities | 2.64% | 3.83% | -3.56% | -1.28% | 8.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -6.19% | 31.93% | 8.10% | 1.20% | 10.26% |
| Capital Leases | -29.48% | 66.53% | -37.85% | -28.10% | -21.91% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -15.56% | -7.22% | 27.65% | 0.00% |
| Total Liabilities | 1.52% | 5.13% | -4.73% | -2.41% | 6.77% |
|
|
|||||
| Common Stock & APIC | 6.39% | -9.98% | 0.26% | 1.23% | 16.29% |
| Retained Earnings | -1.22% | 2.27% | -0.27% | -1.46% | -8.28% |
| Treasury Stock & Other | -0.02% | -0.27% | 0.30% | 5.16% | -6.08% |
| Total Common Equity | 340.78% | -85.33% | 0.78% | 6.43% | 401.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 340.78% | -85.33% | 0.78% | 6.43% | 401.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 608.14% | -32.47% | 18.51% | -52.47% | -1.50% |
| Total Equity | 998.94% | -90.93% | 1.93% | 4.56% | 497.29% |
|
|
|||||